News

How does cyclophosphamide work (mechanism of action)? Cyclophosphamide is a type of medicine known as chemotherapy. Cyclophosphamide is an alkylating agent, which damages DNA, preventing the ...
Although there are many chemotherapy drugs, only some are used to treat rheumatic diseases today. These include: Cyclophosphamide (Cytoxan). This is a more powerful drug and has more side effects ...
Cyclophosphamide injectable solution can be used for short-term or long-term treatment. Some chemotherapy regimens are given as a set number of cycles over a set period of time. Other regimens are ...
It is not a chemotherapy drug. A person takes mycophenolate twice per day and needs to have regular blood tests to check blood counts and liver function. A person can take cyclophosphamide daily ...
Storing sperm before chemotherapy is widely practiced and technically successful. 46 Most cases of cyclophosphamide-induced bladder cancer have been reported in patients who received the drug ...
for chemotherapy? A) AC: Adriamycin and Cytoxin B) CEF: Cytoxan, Epirubicin and Fluorouracil C) AC/T: Adriamycin, Cytoxan and paclitaxel (Taxol) D) TAC: Docetaxel, Adriamycin (doxorubicin ...
doctors typically use a different type of chemotherapy drug, such as cyclophosphamide (Cytoxan). This procedure involves: removing the stem cells from your bone marrow that produce blood cells ...
Attainment of Functional and Social Independence in Adult Survivors of Pediatric CNS Tumors: A Report From the St Jude Lifetime Cohort Study Patients were randomly assigned at study entry to either ...
The aim of this retrospective study was to evaluate the magnitude of the effect of adjuvant classical CMF (cyclophosphamide, methotrexate, and fluorouracil) chemotherapy in a large series of patients ...
These issues are more likely to occur with certain classes of chemotherapy agents, such as the alkylating agents cyclophosphamide and procarbazine, which can harm the ovaries. The risk of ...
Older women with breast cancer are underrepresented in clinical trials, and data on the effects of adjuvant chemotherapy in such patients are scant. We tested for the noninferiority of ...